Dai Horiuchi, PhD, assistant professor of Pharmacology, has been awarded a $450,000 research grant from Susan G. Komen to explore a potential targeted therapy against triple-negative breast cancer.
This year, the University launched a new Center for Synthetic Biology, making Northwestern one of the top three U.S. destinations for research and education in this area.
Faculty from the Division of Hematology/Oncology presented a panel discussion on lymphoma research, treatment and novel trials.
Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.